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Abstract 
AIM: To carry out the comparative nootropic, neuroprotective potentials of two medicinal plant species. 
MATERIAL AND METHODS: For neuroprotective activity; behavior models (elevated plus maze & morris water 
maze), in vivo antioxidant (superoxide dismutase, catalase, lipid peroxidation & reduced glutathione), 
inflammatory markers (IL-1β, IL-6 & TNF-α) and acetylcholine esterase (AChE) assessment procedures followed 
at different dosages i.e. 250 & 500 mg/kg of Evolvulus alsinoides and Centella asiatica ethanolic extracts. At the 
end of the study, it was performed histopathological analysis of the following organs: brain, heart, liver, and 
kidney. 
RESULTS: In oral administration of different doses of ethanolic extracts of both medicinal plants i.e. Sco + EEA 
250 = 2.49 ± 0.29 , Sco + EEA 500 = 2.67 ± 0.36, Sco + ECA 250 = 2.33 ± 0.17, Sco + ECA 500 = 2.77 ± 0.21, 
Sco + EEA + ECA 250 = 2.61 ± 0.32 and Sco + EEA + ECA 500 = 2.79 ± 0.16 U/mg of protein respectively 
against the scopolamine induced group Sco (control) = 5.51 ± 0.35 U/mg of protein extracts shows 
neuroprotective and nootropic activity with reducing AChE level in the brain homogenate of swiss albino mice. 
CONCLUSION: Since the E. alsinoides & C. asiatica are already used in traditional Indian medicine as the 
neuroprotective agent and also found promising effects over inflammatory diseases, wound healing, and 
immunomodulatory activity. The neuroprotective effect of both plants extracts attributed to inhibition of AChE 
activity and improve the spatial memory formation. 
 
 
 
 
 
 
 
Introduction 
 
Alzheimer’s disease is a progressive 
neurodegenerative disease which is characterised by 
the loss of learning and memory abilities with ageing 
[1]. This impairment of memory is correlated with the 
loss of cholinergic neurons [2], [3]. Learning and 
memory are complex processes and thought not to be 
regulated by only one muscarinic receptor subtype; 
scopolamine a non-selective muscarinic receptor 
antagonist has been reported to impair both 
acquisition and long-term memory formation. 
Scopolamine-induced amnesic animal models are 
used to screen for drugs that potentially have anti-
dementia activities by stimulating the cholinergic 
system, make them a candidate for the treatment of 
Alzheimer’s disease [4]. Ayurveda, the Indian system 
of medicine describe a group of medicinal plants 
under the category of ‘Medhya Rasayana’, which 
possess the memory-enhancing effect and facilitate 
learning acquisition. Medicinal plants are rich sources 
of important metabolites, which are potential sources 
of antioxidant, antimicrobial, anti-inflammatory, and 
anticancer activities [5], [6], [7]. The utilisation of 
herbal medicine in treating infectious diseases have 
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been practised for 1000s of years and will continue to 
provide humanity with new remedies [8].  
 
Evolvulus alsinoides L. 
Evolvulus alsinoides L. an important medicinal 
plant is employed for different ailments in India 
traditionally and grows in the open and grassy places 
almost throughout India and mostly in the region from 
India to west Cameroon and widely dispersed 
elsewhere in tropical Africa and worldwide. Some 
vernacular names of the plant in India are 
vishnukranta, vishnugandhiy (sanskrit), shankapushpi 
(hindi). Evolvulus alsinoides L. is used in Ayurveda as 
a brain tonic in the treatment of neurodegenerative 
diseases, asthma and amnesia [9].  
 
Centella asiatica  
Centella asiatica is a very important medicinal 
herb also known as Mandukparni, which has been 
used as a medicine in the Ayurvedic tradition of India 
for thousands of years and mentioned in many 
classical texts of Ayurveda. Centella asiatica (CA) is a 
rejuvenative nervine recommended for nervous 
disorders, epilepsy, senility and premature ageing and 
several other medical conditions. As a brain tonic, it is 
said to aid intelligence and memory [10]. The extract 
of Centella asiatica especially from roots and leaves 
contain a high anti-oxidative activity, which was as 
good as tocopherol, a natural anti-oxidant, have been 
reported to play a significant role in wound healing 
[11]. Centella asiatica extract contains four principle 
bioactive compounds: asiatic acids, made classic 
acid, asiaticoside and madecassoside [12], [13], in 
which asiaticoside was identified as the main active 
constituent responsible for wound healing.  
 We are working on the development of anti-
dementia natural drug using an in vivo screening of 
herbal materials due to their safety and cost-
effectiveness [14]. 
 
 
Material and Methods 
 
Plant material 
Whole plant material of Centella asiatica and 
Evolvulus alsinoides were collected from village 
Ramnapur, Varanasi, Uttar Pradesh, India in October 
2015 and authentication was done by Department of 
Botany, Banaras Hindu University, India and also 
herbarium of Centella asiatica (voucher specimen no. 
Apia/02/2015) and Evolvulus alsinoides (voucher 
specimen no. Convolvul./03/2015) of plant was 
deposited in the Department of Botany, Banaras 
Hindu University, India. 
Preparation of extracts 
The extraction of whole plants was done with 
Soxhlet method in ethanolic solvents at 72-82°C for 
72 hours. The Soxhlet extraction has widely been 
used for extracting valuable bioactive compounds 
from various natural sources. It is used as a model for 
the comparison of new extraction alternatives. A small 
amount of dry sample is placed in a thimble. The 
thimble is then placed in distillation flask which 
contains the solvent of particular interest. After 
reaching an overflow level, the solution of the thimble-
holder is aspirated by a siphon. Siphon unloads the 
solution back into the distillation flask. This solution 
carries extracted solutes into the bulk liquid. The 
solute remains in the distillation flask, and solvent 
passes back to the solid bed of plant. The 
processrepeatedly runs until the extraction is 
completed. 
 
Preparation of extract samples 
Ethanolic extracts of C. asiatica (ECA) and E. 
alsinoides (EEA) were solubilized in distilled water to 
obtain solutions of 250 and 500 mg/ml [15]. 
 
Animals 
The experimental Swiss albino mice were 
issued by Animal house of Institute of Medical 
Sciences, Banaras Hindu University Varanasi, Uttar 
Pradesh. Animals were divided into experimental 
groups, housed in plastic cages and maintained on a 
12-hour light and 12-hour dark cycle. They were given 
standard food and water ad libitum. The Central 
Animal Ethical Committee of Banaras Hindu 
University approved all experimental procedures 
(CAEC/196). 
 
Experimental design and Drug 
administration 
Scopolamine (1.0 mg/kg; dissolved in distilled 
water) was administered intraperitoneal (i.p.) to the 
experimental animals. The ethanolic extracts of 
Evolvulus alsinoides (EEA) and Centella asiatica 
(ECA) in the following doses: EEA 250 mg/kg/day & 
500 mg/kg/day, ECA 250 mg/kg/day & 500 mg/kg/day 
and combination of EEA + ECA 250 mg/kg/day & 500 
mg/kg/day, dissolved in 0.3% CMC and was 
administered orally (p.o.). Nine groups, each 
consisting of 6 animals, were included in the study.  
Group I (normal) was treated with vehicle 
daily (0.3% CMC; p.o).  
Group II (Sco control) was treated with 
scopolamine (1.0 mg/kg/day; i.p.).  
Group III (Sco + Doz) was treated with a 
donepezil (1.5 mg/kg/day; i.p.) and scopolamine (1.0 
mg/kg/day; i.p.).  
Yadav et al. Neuroprotective Activity of Evolvulus Alsinoides & Centella Asiatica Ethanolic Extracts in Scopolamine-Induced Amnesia 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci.                                                                                                                                                                                                         3 
 
Group IV (Sco + EEA 250) was treated with 
low dose EEA (250 mg/kg/day; p.o.) and scopolamine 
(1.0 mg/kg/day; i.p.).  
Group V (Sco + EEA 500) was treated with 
high dose of EEA (500 mg/kg/day; p.o.) and 
scopolamine (1.0 mg/kg/day; i.p.).  
Group VI (Sco + ECA 250) was treated with 
low dose ECA (250 mg/kg/day; p.o.) and scopolamine 
(1.0 mg/kg/day; i.p.).  
Group VII (Sco + ECA 500) was treated with 
high dose of ECA (500 mg/kg/day; p.o.) and 
scopolamine (1.0 mg/kg/day; i.p.).  
Group VIII (Sco + EEA + ECA 250) was 
treated with low dose of EEA (250 mg/kg/day; PO) & 
ECA (250 mg/kg/day; p.o.) and scopolamine (1.0 
mg/kg/day; i.p.).  
Group IX (Sco + EEA + ECA 500) was treated 
with high dose of EEA (500 mg/kg/day; p.o.) & ECA 
(500 mg/kg/day; p.o.) and scopolamine (1.0 
mg/kg/day; i.p.). 
 
Behavioural study 
Elevated plus maze 
The elevated plus maze (EPM) is designed to 
study the behavioural pattern of experimental animals 
such as sensitivity to external stimuli (exteroceptive 
behaviour), anxiety, exploration as well as learning 
and memory [16], [17]. The EPM consists of four arms 
(two open and two closed), each 49 cm x 10 cm, with 
40 cm high walls in closed arms and the open roof. 
The whole structure is elevated 50 cm above the 
ground. On the 10th day, 60 min after the drug 
treatment, each mice was placed at the end of an 
open arm, facing away from the central platform. The 
time is taken by the mice to enter any of the closed 
arms was recorded and considered as the transfer 
latency (TL) and served as a parameter for 
acquisition/ learning. If the mice did not enter into any 
one of the closed arms within 180 sec, it was gently 
pushed into one of the two closed arms, and the TL 
was assigned as 180 sec. For the next 15 sec, the 
mice were allowed to explore the maze before 
returning it to its home cage. On the 14th day, TL was 
recorded again, which served as a parameter for 
retention of memory. Between each session, the 
maze was carefully cleaned with 30% ethanol tissue 
to remove any olfactory cues. 
 
Morris water maze 
The Morris water maze (MWM) [18], [19] test 
was performed to assess the learning and spatial 
memory of the experimental animals. The advantage 
of MWM over other models of learning and memory 
lies in the fact that no motivational stimuli such as 
food and water deprivation, electrical stimulation and 
buzzer sounds are applied. The apparatus consists of 
a circular pool (45 cm in height and 100 cm in 
diameter) with a featureless inner surface. The pool 
was filled with opaque water, maintained at the 
temperature of 22 ± 2°C, to a height of 30 cm, and 
was divided into four quadrants of equal area, marked 
by different visual cues. A platform (29 cm X 6 cm) 
was placed one centimetre below the level of water at 
the centre of one of the four quadrants, which was 
considered as the target quadrant. The position of the 
platform was kept unaltered throughout the 
experiment. The MWM test was performed on the 
10th day after drug administration was started. On the 
first experimental day, the mice were allowed to 
acclimatise in the pool and swim for 120 sec without 
the platform. During the next four consecutive days, 
each animal received four learning trials of 120 sec 
with an inter-trial interval of 60 sec. 
For each learning trial, the mice were placed 
in the water facing the pool wall diagonally opposite to 
the quadrant in which the platform was kept. The time 
taken by the animal to locate the submerged platform 
was recorded as Escape latency time (ELT) for each 
trial. If the animal were unable to locate the platform 
within 120 sec, it was directed to the platform and 
allowed to rest there for 60 sec, and in this case, the 
ELT was recorded as 120 sec. These sessions were 
recorded as hidden platform trials for acquisition test. 
On the 14th day after the learning trial session, the 
platform was removed from the pool, and the mice 
were subjected to a Probe trial session to assess 
memory retention. Each mouse was placed into the 
water diagonally opposite to the target quadrant, and 
for 60 sec was allowed to swim and find the quadrant 
in which the platform was previously placed. The 
swimming time of the animal to reach the target 
quadrant was recorded as probe trial memory 
retention test. 
 
Preparation of Brain homogenate  
On the terminal experimental day, animals 
were euthanized, and the whole brains of all mice 
were isolated after performing cardiac perfusion with 
normal saline for biochemical estimations. Then 
further rinsed in ice-cold isotonic saline and were 
homogenized with ice-cold 0.1 M phosphate buffer 
saline (pH 7.4) to form 10% w/v homogenates. These 
homogenates were then further centrifuged at -4°C 
(10,000 rpm; C-24 cooling centrifuge instrument, 
Model no. C-24 Remi, India) for 15 min and the 
supernatant was used for estimation of biochemical 
parameters [20]. 
 
In vivo antioxidants assessment 
Assessment of Superoxide dismutase 
activity 
Every 3 ml of reaction mixture contained 2.8 
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ml of potassium phosphate buffer (0.1 M, pH 7.4), 0.1 
ml of brain homogenate and 0.1 ml of pyrogallol 
solution (2.6 mM in 10 mM HCl). The change in 
absorbance was recorded at 325 nm for 5 min with 30 
sec. Interval. One unit of SOD is equivalent to the 
amount of enzyme required to cause 50% inhibition of 
pyrogallol autoxidation per 3 ml of the assay mixture 
[21].  
 
Assessment of Catalase activity 
The reaction mixture contained 2.0 ml of 
diluted homogenate in 0.1 M phosphate buffer 
(enzyme extract). The reaction was started by adding 
1.0 ml of 200 mM H2O2. The decrease in OD per min 
was recorded against the blank (all the reagents 
except enzyme extract) for 3 min at 240 nm at 
intervals of 15 sec. CAT activity was expressed as 
U/mg protein [22]. 
 
Assessment of Lipid peroxidation activity 
To 100 μl of tissue homogenate, 1.5 ml of 
10% TCA solution was added. After 10 min, centrifuge 
at 5000 rpm for 10 min. The supernatant was 
separated and mixed with 1.5 ml of TBA. The tubes 
were kept in boiling water bath for 30 min to complete 
reaction and were cooled under tap water. The 
absorbance of the sample at 535 nm against distilled 
water [23]. 
 
Assessment of Reduced glutathione (GSH) 
activity 
The GSH assays were performed as 
described by Smith I K et al., [24]. In GSH assay, 3 ml 
of reaction mixture consisted of 2.9 ml of 5, 5-dithiobis 
(2-nitrobenzoate) (DTNB) prepared in potassium 
phosphate buffer (0.1 M, pH 7.4) and 0.1 ml of tissue 
homogenate. The reaction mixture was incubated at 
37°C for 15 min, and the absorbance was recorded at 
412 nm, and the results were expressed as GSH/mg 
protein. 
 
Analysis of IL-1β, IL-6 and TNF-α in the 
brain 
The levels of IL-1β, IL-6, and TNF-α in the 
brain homogenates were determined using 
commercial (Elabscience) ELISA kits according to the 
manufacturer’s instructions. The levels of these 
cytokines in the brain tissues were normalized to the 
protein content. 
 
AChE estimation 
AChE activity was estimated in the whole 
brain homogenates according to Ellman’s method 
[25]. Briefly, the brain homogenate was incubated for 
5 min with 2.7 ml of phosphate buffer and 0.1 ml of 5, 
5-dithiobis (2-nitrobenzoate) (DTNB). Further, 0.1 ml 
of freshly prepared acetylcholine iodide (pH 8) was 
added, and the change in absorbance was recorded 
at 412 nm.  
 
Statistical analysis 
The relative haematological and biochemical 
data were expressed as the mean ± standard error of 
the mean (SEM). Data were submitted to analysis of 
variance (one-way ANOVA) followed by Dunnett 
multiple comparison tests. The results were 
expressed as mean ± SEM. The software GraphPad 
Prism 6.0 (GraphPad Software, USA) was used for 
statistical analysis. P < 0.05 were considered 
statistically significant. 
 
 
Results 
 
Behavioral study 
Elevated plus maze 
The elevated plus maze (EPM) was used to 
study the behavioral pattern of mice such as anxiety, 
exploration as well as learning and memory and 
results are shown in Figure 1. At the days 1
st
, 6
th
, 10
th
 
and 14
th
 with transfer latency time (sec) for Sco + ECA 
250 = 23 ± 0.7, 19 ± 2.27, 18 ± 0.67, 16 ± 0.73; Sco + 
ECA 500 = 27 ± 2.39, 26 ± 0.79, 20 ± 0.97, 17 ± 0.97; 
Sco + EEA + ECA 250 = 20 ± 1.73, 18 ± 1.32, 18 ± 
0.51, 16 ± 0.72 groups have shown good activity in 
respect to Sco (control) = 45 ± 2.1, 48 ± 2.1, 50 ± 2.3, 
52 ± 2.3 group and Sco + Doz (standard)= 22 ± 1.28, 
20 ± 2.86, 18 ± 2.3, 14 ± 2.52 group.  
 
Figure 1: Transfer latency time for all groups in elevated plus maze 
behavioral study. Data expressed as mean ± sem, n = 6. P < 0.01, 
compared with the Sco group and P < 0.01 compared to the normal 
group using one-way ANOVA followed by Dunnett’s test as a post –
ANOVA test 
 
Morris water maze 
The Escape Latency Time (ELT) was 
measured to assess spatial memory in mice, and the 
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results are shown in Figure 2. On 1
st
 and 6
th
 day and 
we found that there was no significant difference in 
ELT in all mice groups. On the 10
th
 and 14
th
 day all 
plant extract treated groups were found to improve the 
spatial memory in a dose-dependent manner with a 
significant (P < 0.01).  
On 14
th
 day plant extracts treatment groups 
significantly reduced the ELT at Sco + EEA 250 = 56 
± 2.88, 54 ± 2.3, 43 ± 1.85, 36 ± 1.72; Sco + ECA 250 
= 49 ± 2.33, 46 ± 2.5, 46 ± 2.88, 36 ± 2.98; Sco + ECA 
500 = 48 ± 1.95, 47 ± 1.45, 45 ± 1.73, 24 ± 1.5; Sco + 
EEA + ECA 500 = 44 ± 3.2, 43 ± 2.66, 33 ± 1.85, 24 ± 
1.76 & Sco + Doz (standard) = 39 ± 2.66, 38 ± 1.62, 
35 ± 1.73, 33 ± 2.88 and showed significantly 
improvement in spatial memory on both the days 
during treatment regimen (P < 0.01) in comparison 
with Scopolamine treated mice group Sco (control) = 
92 ± 2.8, 95 ± 3.4, 112 ± 1.76, 116 ± 1.45.  
 
Figure 2: Escape Latency Time (ELT) for all groups in morris water 
maze behavioral study. Data expressed as mean ± sem, n = 6. P < 
0.01, compared with the Sco group and P < 0.01 compared to the 
normal group using one-way ANOVA followed by Dunnett’s test as 
a post-ANOVA test 
 
In vivo antioxidant activity 
Super oxide Dismutase (SOD) 
SOD is the major antioxidant enzyme 
scavenging the free radicals generated during 
oxidative stress were estimated and results are 
showed in Figure 3. The Sco + EEA 250 = 146 ± 6.01, 
Sco + EEA 500 = 148.66 ± 5.23 & Sco + ECA 250 = 
148.89 ± 6.63 treatment groups significantly increased 
the SOD activity at all doses levels (P < 0.01) except 
Sco + ECA 500 = 141.13 ± 5.18, Sco + EEA + ECA 
250 = 141.63 ± 6.11 and Sco + EEA + ECA 500 = 
131.55 ± 4.25 found not significant in comparison with 
Sco (Control) = 119.78 ± 4.57 treated mice group.  
Sco + Doz (standard) = 150.52 ± 4.61 
administration also showed protection from oxidative 
stress by elevating the SOD activity as compared to 
Sco (control) mice (P < 0.01). 
 
Figure 3: Super oxide dismutase activity in all mice groups show 
significant increase. Data expressed as mean ± sem, n = 6. P < 
0.01, compared with the Sco (control) group and P<0.01 compared 
to the normal group using one-way ANOVA followed by Dunnett’s 
test as a post-ANOVA test. (*P < 0.05, **P < 0.01, ***P < 0.001, ns 
= not significant) 
 
Catalase 
In the all treatment groups; Sco + EEA 500 = 
126.8 ± 5.7, Sco + ECA 500 = 126.0 ± 5.2 & Sco + 
EEA + ECA 500 = 126.7 ± 5.8 & Sco + Doz (standard) 
= 131.1 ± 4.7 significantly increased the catalase 
activity (P < 0.01) except Sco + ECA 250 = 103.1 ± 
6.6 which found not significant in comparison with Sco 
(control) = 98.32 ± 5.3 treated mice group (Figure 4).  
 
Figure 4: Catalase activity in all mice groups and Data expressed 
as mean ± sem, n = 6. P < 0.01, compared with the Sco group and 
P < 0.01 compared to the normal group using one-way ANOVA 
followed by Dunnett’s test as a post-ANOVA test. (*P < 0.05, **P < 
0.01, ***P < 0.001, ns = not significant) 
 
Lipid Peroxidation 
In the all treatment groups; Sco + EEA 250 = 
0.48 ± 0.05, Sco + EEA 500 = 0.37 ± 0.03 & Sco + 
ECA 500 = 0.45 ± 0.02 and Sco + EEA + ECA 250 = 
0.6 ± 0.03 significantly increased the LPO activity (P < 
0.05) except Sco + ECA 250 = 0.66 ± 0.03 and Sco + 
EEA + ECA 500 = 0.7 ± 0.03 in comparison with Sco 
(control) = 0.81 ± 0.06 treated mice group as well as 
Sco + Doz (standard) = 0.45 ± 0.02 also decreased 
the elevated MDA levels. 
 
Figure 5: Lipid peroxidation assay in all mice groups 
showed significant decrease in comparison to Sco group. Data 
expressed as mean ± sem, n = 6. P < 0.01, compared with the Sco 
(control) group and P < 0.01 compared to the normal group using 
one-way ANOVA followed by Dunnett’s test as a post-ANOVA test. 
(*P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant) 
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Reduced glutathione (GSH) 
Reduced glutathione (GSH) level were 
increased after treatment with all the experimental 
animal groups; Sco + EEA 250 = 4.75 ± 0.47, Sco + 
EEA 500 = 4.61 ± 0.18, Sco + ECA 500 = 4.26 ± 0.06 
& Sco + EEA+ ECA 250 = 4.18 ± 0.09 which found to 
be significant (P < 0.05) except Sco + ECA 250 = 4.08 
± 0.16 and Sco + EEA + ECA 500 = 4.02 ± 0.11 which 
found not significant in comparison to Sco (control) = 
3.2 ± 0.26 treated group and Sco + Doz (standard) = 
4.8 ± 0.15 significantly elevated GSH levels (P < 
0.05). 
 
Figure 6: Reduced glutathione activity in all mice groups showed 
significant increase in comparison to Sco group. Data expressed as 
mean ± sem, n = 6. P < 0.05, compared with the Sco group and P < 
0.05 compared to the normal group using one-way ANOVA followed 
by Dunnett’s test as a post-ANOVA test. (*P < 0.05, **P < 0.01, ***P 
< 0.001, ns = not significant) 
 
Inflammatory markers 
IL-1β 
The effect of plant extracts treated at different 
concentrations Sco + EEA 250 = 394.1 ± 23.03, Sco + 
EEA 500 = 355.5 ± 14.64, Sco + ECA 500 = 387.26 ± 
25.3 & Sco + EEA + ECA 250 = 386.21 ± 14.38 & Sco 
+ Doz (standard) = 396.38 ± 15.28 on whole brain 
markedly decrease the levels of IL-1β when compared 
with Sco (control) = 485.85 ± 14.76 group (P < 0.01) 
although Sco + ECA 250 = 405.5 ± 23.16 and Sco + 
EEA + ECA 500 = 406.38 ± 24.65 groups founds to be 
not significant. 
 
Figure 7: Effect of plant extracts on brain IL-1β levels in Sco 
induced mice model. Data expressed as mean ± sem, n = 6. P < 
0.01, compared with the Sco group and P < 0.01 compared to the 
normal group using one-way ANOVA followed by Dunnett’s test as 
a post-ANOVA test. (*P < 0.05, **P < 0.01, ***P < 0.001, ns= not 
significant) 
 
IL-6  
Figure 8 shows the effect of plant extracts on 
the IL-6 levels in the whole brain and we found that 
Sco + EEA 500 = 395.54 ± 14.17, Sco + ECA 250 = 
398.87 ± 16.25 Sco + ECA 500 = 395.12 ± 23.68 & 
Sco + EEA + ECA 250 = 413.66 ± 20.26 & Sco + Doz 
(standard) = 360.54 ± 20.86 except Sco + EEA 250 = 
465.75 ± 13.62 all treatment groups markedly 
decrease the levels of IL-6 when compared with Sco 
(control) = 541.58 ± 19.82 group. 
 
Figure 8: Effect of plant extracts on brain IL-6 levels in Sco induced 
mice model. Data expressed as mean ± sem, n = 6. P < 0.01, 
compared with the Sco group and P < 0.01 compared to the normal 
group using one-way ANOVA followed by Dunnett’s test as a post-
ANOVA test. (*P < 0.05, **P < 0.01, ***P < 0.001, ns = not 
significant) 
 
TNF-α 
Figure 9 shows the effect of plant extracts on 
the TNF-α level in the whole brain on treatment with 
Sco + EEA 250 = 112.17 ± 11.52; Sco + EEA 500 = 
108.97 ± 12.32; Sco + ECA 250 = 130.12 ± 11.50; 
Sco + ECA 500 = 176.92 ± 14.72; Sco + EEA + ECA 
250 = 109.61 ± 15.86; Sco + EEA + ECA 500 = 
107.69 ± 14.63 & Sco + Doz (standard) = 83.97 ± 
14.42 subsequently decrease the levels of TNF-α 
activity when compared with Sco (control) = 233.97 ± 
12.4 group. 
 
Figure 9: Effect of plant extracts on brain TNF-α levels in Sco 
induced mice model. Data expressed as mean ± sem, n = 6. P < 
0.01, compared with the Sco group and P < 0.01 compared to the 
normal group using one-way ANOVA followed by Dunnett’s test as 
a post-ANOVA test. (*P < 0.05, **P < 0.01, ***P < 0.001, ns = not 
significant) 
 
Acetylcholine esterase (AChE) activity 
Sco administration resulted in significant 
increase in the brain AChE activity. All the treatment 
groups Sco + EEA 250 = 2.49 ± 0.29; Sco + EEA 500 
= 2.67 ± 0.36; Sco + ECA 250 = 2.33 ± 0.17; Sco + 
ECA 500 = 2.77 ± 0.21; Sco + EEA + ECA 250 = 2.61 
± 0.32; Sco + EEA + ECA 500 = 2.79 ± 0.16 & Sco + 
Doz (standard) = 2.74 ± 0.3 significantly inhibit the 
AChE activity in comparison with Sco (control) = 5.51 
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± 0.35 treated mice group.  
 
Figure 10: Acetylcholine esterase activity in all mice groups found 
significant in comparison to Sco group. Data expressed as mean ± 
sem, n = 6. P < 0.01, compared with the Sco group and P < 0.01 
compared to the normal group using one-way ANOVA followed by 
Dunnett’s test as a post-ANOVA test. (*P < 0.05, **P < 0.01, ***P < 
0.001, ns = not significant) 
 
 
 
Discussion 
 
In neurodegeneration, oxidative stress plays 
an important role in the ageing process, and the brain 
is highly susceptible to the oxidative imbalance due to 
its high energy demand, high oxygen consumption 
[26]. Basal forebrain and amygdala are involved in 
learning and memory formation and are more 
vulnerable areas susceptible to oxidative stress [27]. 
Mitochondrial dysfunction caused by increased 
reactive oxygen species generation has been involved 
in ageing and neurodegenerative disorders [28]. In 
this study, Scopolamine treatment significantly 
decreased the reactive oxygen species scavenging 
enzymes activities like superoxide dismutase, 
catalase and also reduced glutathione levels in brain 
tissue. Scopolamine treatment also significantly 
increased lipid peroxidation as compared to the 
normal group. Both plants extract me. e. EEA, ECA, 
EEA + ECA treatments were found to significantly 
elevate the SOD, catalase activity, lipid peroxidation 
activity and reduced glutathione levels in comparison 
with Scopolamine group. The expression of cytokine 
receptors is temporally and spatially regulated in the 
central nervous system, and they are closely involved 
in cell proliferation, gliogenesis, neurogenesis, cell 
migration, apoptosis, and synaptic release of 
neurotransmitters [29], [30]. The level of cytokines IL-
1β, IL-6 and TNF-α are significantly decreased on 
treatment with plant extracts which increased by 
Scopolamine administration. The elevated activity of 
AChE leads to increased degradation of acetylcholine 
(Ach) neurotransmitter and which in turn declines the 
ACh pool in the brain which is essential in learning 
and memory [31]. Scopolamine administration 
amplifies the AChE activity which is one of the major 
causes for the cholinergic deficit occurrence after its 
administration [20]. In this study we found that 
treatment with both plants ethanolic extracts 
significantly reduced the AChE activity as compared 
to the Scopolamine treated mice. It reveals that 
inhibition of AChE activity by plant extracts have a 
protective role in acetylcholine degradation and 
improved the cholinergic neurotransmission. Thus, 
plant extracts reduced the cholinergic deficits 
produced by Scopolamine administration resulting in 
an enhanced neuroprotective effect.  
Since the E. alsinoides & C. asiatica are 
already used in traditional Indian medicine as the 
neuroprotective agent and also found promising 
effects over inflammatory diseases, wound healing, 
and immunomodulatory activity. The neuroprotective 
effect of both plants extracts attributed to inhibition of 
AChE activity and improve the spatial memory 
formation. The neuroprotective activity could be 
ascribed to extracts strong antioxidant potential, 
inhibitory role on AChE activity. The research above 
findings of this study prospect ethanolic extracts of 
both plants, i.e. EEA, ECA and EEA + ECA extracts 
as the promising therapeutic candidate for 
neurodegenerative diseases. 
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